14th Nov 2013 10:53
(An item published at 1310 GMT, November 13, misstated Richard Morgan's position at Kromek. The correct version follows.)
November 13, LONDON (Alliance News) - Amphion Innovations PLC Wednesday said that its partner company Kromek Group PLC had launched its initial public offering on AIM.
After the placing Amphion holds a 11.6% stake in Kromek. Chief Executive Officer Richard Morgan is also the chairman of Kromek.
In a separate statement the company announced that its partner company WellGen Inc. had been awarded a grant of USD293,244 by the National Institute of Health.
Amphion is a private equity firm focused on the development of medical and technology businesses. Its shares last traded at 4.45 pence.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
AMP.L